This article was originally published in The Tan Sheet
Updates to "Drug Facts" labeling for Pfizer's OTC sleep aid cleared by FDA June 3 through supplemental NDAs 18-066/S-011 and S-013. Changes provide for "new labeling for two additional package sizes (40- and 64-count) and revised labeling for four package sizes (8-, 16-, 32- and 48-count)," agency's approval letter states...
You may also be interested in...
If demand-side pressures on the life science sector were not enough, generic price erosion, debt repayment and extended restructurings are worsening the generic pharmaceutical investment proposition.
California state Attorney General Xavier Becerra promised during two US Senate committee hearings that, if confirmed as Secretary of Health and Human Services, he will let science shape HHS policy.
New treatments for advanced endometrial cancer and hereditary angioedema are among six drugs that have just been recommended for EU-wide approval. Harmonized EU advice has also been issued in relation to an investigational antibody combination for treating COVID-19.